• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Understanding Pseudomonas status among adults with cystic fibrosis: a real-world comparison of the Leeds criteria against clinicians' decision.了解成人囊性纤维化患者中的铜绿假单胞菌状况:利兹标准与临床医生决策的真实世界比较。
Eur J Clin Microbiol Infect Dis. 2018 Apr;37(4):735-743. doi: 10.1007/s10096-017-3168-4. Epub 2018 Jan 6.
2
A comparison of the CFHH criteria against the Leeds criteria in determining the Pseudomonas aeruginosa status among adults with cystic fibrosis.比较 CFHH 标准与利兹标准在确定成年囊性纤维化患者铜绿假单胞菌状态中的应用。
Respir Med. 2020 Sep;171:106103. doi: 10.1016/j.rmed.2020.106103. Epub 2020 Jul 28.
3
Evaluating the "Leeds criteria" for Pseudomonas aeruginosa infection in a cystic fibrosis centre.在一家囊性纤维化中心评估铜绿假单胞菌感染的“利兹标准”。
Eur Respir J. 2006 May;27(5):937-43. doi: 10.1183/09031936.06.00100805.
4
Reduction in prevalence of chronic Pseudomonas aeruginosa infection at a regional pediatric cystic fibrosis center.某地区儿科囊性纤维化中心慢性铜绿假单胞菌感染患病率的降低
Pediatr Pulmonol. 2004 Feb;37(2):104-10. doi: 10.1002/ppul.10401.
5
Clinical and microbiological characteristics of cystic fibrosis adults never colonized by Pseudomonas aeruginosa: Analysis of the French CF registry.囊性纤维化成人从未被铜绿假单胞菌定植的临床和微生物学特征:法国 CF 登记处的分析。
PLoS One. 2019 Jan 8;14(1):e0210201. doi: 10.1371/journal.pone.0210201. eCollection 2019.
6
Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.标准抗菌药敏试验与生物膜抗菌药敏试验用于指导囊性纤维化患者的抗生素治疗
Cochrane Database Syst Rev. 2020 Jun 10;6(6):CD009528. doi: 10.1002/14651858.CD009528.pub5.
7
Chronic Pseudomonas aeruginosa infection and respiratory muscle impairment in cystic fibrosis.囊性纤维化患者中慢性铜绿假单胞菌感染与呼吸肌功能障碍。
Respir Care. 2014 Mar;59(3):363-70. doi: 10.4187/respcare.02549. Epub 2013 Aug 27.
8
Detection of viable but non-culturable Pseudomonas aeruginosa in cystic fibrosis by qPCR: a validation study.qPCR 检测囊性纤维化中存活但不可培养的铜绿假单胞菌:一项验证研究。
BMC Infect Dis. 2018 Dec 27;18(1):701. doi: 10.1186/s12879-018-3612-9.
9
Pseudomonas aeruginosa antibiotic resistance in Australian cystic fibrosis centres.澳大利亚囊性纤维化中心的铜绿假单胞菌抗生素耐药性。
Respirology. 2016 Feb;21(2):329-37. doi: 10.1111/resp.12714. Epub 2015 Dec 28.
10
Epidemiology and clinical impact of Pseudomonas aeruginosa infection in cystic fibrosis using AP-PCR fingerprinting.运用扩增片段长度多态性聚合酶链反应指纹图谱技术研究铜绿假单胞菌感染在囊性纤维化中的流行病学及临床影响
J Infect. 1998 Sep;37(2):151-8. doi: 10.1016/s0163-4453(98)80170-9.

引用本文的文献

1
Ecological patterns and processes of temporal turnover within lung infection microbiota.肺部感染微生物组中时间转换的生态模式和过程。
Microbiome. 2024 Mar 25;12(1):63. doi: 10.1186/s40168-024-01780-6.
2
Nebuliser systems for drug delivery in cystic fibrosis.雾化器系统在囊性纤维化中的药物输送。
Cochrane Database Syst Rev. 2023 Nov 9;11(11):CD007639. doi: 10.1002/14651858.CD007639.pub3.
3
Higher levels of Pseudomonas aeruginosa LasB elastase expression are associated with early-stage infection in cystic fibrosis patients.铜绿假单胞菌 LasB 弹性蛋白酶表达水平升高与囊性纤维化患者早期感染有关。
Sci Rep. 2023 Aug 30;13(1):14208. doi: 10.1038/s41598-023-41333-9.
4
Digital technology for early identification of exacerbations in people with cystic fibrosis.数字技术用于早期识别囊性纤维化患者的恶化情况。
Cochrane Database Syst Rev. 2023 Apr 14;4(4):CD014606. doi: 10.1002/14651858.CD014606.pub2.
5
Psychological interventions for improving adherence to inhaled therapies in people with cystic fibrosis.心理干预对改善囊性纤维化患者吸入治疗依从性的作用。
Cochrane Database Syst Rev. 2023 Mar 29;3(3):CD013766. doi: 10.1002/14651858.CD013766.pub2.
6
Role of Tobramycin in the Induction and Maintenance of Viable but Non-Culturable in an In Vitro Biofilm Model.妥布霉素在体外生物膜模型中诱导和维持活的但不可培养状态的作用。
Antibiotics (Basel). 2020 Jul 10;9(7):399. doi: 10.3390/antibiotics9070399.
7
Impact of Coexistence Phenotype Between and Isolates on Clinical Outcomes Among Cystic Fibrosis Patients.与 分离株共存表型对囊性纤维化患者临床结局的影响。
Front Cell Infect Microbiol. 2020 Jun 3;10:266. doi: 10.3389/fcimb.2020.00266. eCollection 2020.
8
Prevention of chronic infection with Pseudomonas aeruginosa infection in cystic fibrosis.预防囊性纤维化患者铜绿假单胞菌慢性感染。
Curr Opin Pulm Med. 2019 Nov;25(6):636-645. doi: 10.1097/MCP.0000000000000616.
9
Pragmatic criteria to define chronic pseudomonas aeruginosa infection among adults with cystic fibrosis.在成年囊性纤维化患者中定义慢性铜绿假单胞菌感染的实用标准。
Eur J Clin Microbiol Infect Dis. 2018 Nov;37(11):2219-2222. doi: 10.1007/s10096-018-3358-8. Epub 2018 Aug 18.

本文引用的文献

1
Accurate reporting of adherence to inhaled therapies in adults with cystic fibrosis: methods to calculate "normative adherence".准确报告成年囊性纤维化患者吸入疗法的依从性:计算“规范依从性”的方法
Patient Prefer Adherence. 2016 May 23;10:887-900. doi: 10.2147/PPA.S105530. eCollection 2016.
2
Microbiological yield from induced sputum compared to oropharyngeal swab in young children with cystic fibrosis.在患有囊性纤维化的幼儿中,诱导痰与口咽拭子相比的微生物培养产量。
J Cyst Fibros. 2016 Sep;15(5):605-10. doi: 10.1016/j.jcf.2016.01.001. Epub 2016 Jan 26.
3
How and why to monitor Pseudomonas aeruginosa infections in the long term at a cystic fibrosis centre.在囊性纤维化中心长期监测铜绿假单胞菌感染的方式及原因。
J Hosp Infect. 2016 Jan;92(1):54-60. doi: 10.1016/j.jhin.2015.09.010. Epub 2015 Oct 8.
4
Changing Epidemiology of the Respiratory Bacteriology of Patients With Cystic Fibrosis.囊性纤维化患者呼吸道细菌学的流行病学变化
Chest. 2016 Feb;149(2):390-400. doi: 10.1378/chest.15-0676. Epub 2016 Jan 12.
5
A phase 3, open-label, randomized trial to evaluate the safety and efficacy of levofloxacin inhalation solution (APT-1026) versus tobramycin inhalation solution in stable cystic fibrosis patients.一项评估左氧氟沙星吸入溶液(APT-1026)与妥布霉素吸入溶液在稳定期囊性纤维化患者中的安全性和疗效的 3 期、开放标签、随机试验。
J Cyst Fibros. 2015 Jul;14(4):507-14. doi: 10.1016/j.jcf.2014.12.013. Epub 2015 Jan 13.
6
Cystic Fibrosis Foundation pulmonary guideline. pharmacologic approaches to prevention and eradication of initial Pseudomonas aeruginosa infection.囊性纤维化基金会肺部指南:预防和清除初始绿脓假单胞菌感染的药物治疗方法。
Ann Am Thorac Soc. 2014 Dec;11(10):1640-50. doi: 10.1513/AnnalsATS.201404-166OC.
7
Pseudomonas aeruginosa in cystic fibrosis patients with G551D-CFTR treated with ivacaftor.接受依伐卡托治疗的携带G551D-CFTR的囊性纤维化患者中的铜绿假单胞菌
Clin Infect Dis. 2015 Mar 1;60(5):703-12. doi: 10.1093/cid/ciu944. Epub 2014 Nov 25.
8
Changes in the lung microbiome following lung transplantation include the emergence of two distinct Pseudomonas species with distinct clinical associations.肺移植后肺部微生物群的变化包括出现两种具有不同临床关联的不同假单胞菌属物种。
PLoS One. 2014 May 15;9(5):e97214. doi: 10.1371/journal.pone.0097214. eCollection 2014.
9
Clinical outcomes after initial pseudomonas acquisition in cystic fibrosis.囊性纤维化患者初次感染铜绿假单胞菌后的临床结局
Pediatr Pulmonol. 2015 Jan;50(1):42-8. doi: 10.1002/ppul.23036. Epub 2014 Mar 18.
10
Serum antibodies to Pseudomonas aeruginosa in cystic fibrosis as a diagnostic tool: a systematic review.囊性纤维化患者血清中抗铜绿假单胞菌抗体作为诊断工具的系统评价
J Cyst Fibros. 2014 Sep;13(5):499-507. doi: 10.1016/j.jcf.2014.01.005. Epub 2014 Feb 9.

了解成人囊性纤维化患者中的铜绿假单胞菌状况:利兹标准与临床医生决策的真实世界比较。

Understanding Pseudomonas status among adults with cystic fibrosis: a real-world comparison of the Leeds criteria against clinicians' decision.

机构信息

School of Health and Related Research (ScHARR), University of Sheffield, Regent Court, 30 Regent Street, Sheffield, S1 4DA, UK.

Sheffield Adult Cystic Fibrosis Centre, Brearley Outpatient, Northern General Hospital, Herries Road, S5 7AU, Sheffield, UK.

出版信息

Eur J Clin Microbiol Infect Dis. 2018 Apr;37(4):735-743. doi: 10.1007/s10096-017-3168-4. Epub 2018 Jan 6.

DOI:10.1007/s10096-017-3168-4
PMID:29307004
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5978898/
Abstract

Pseudomonas aeruginosa status influences cystic fibrosis (CF) clinical management but no 'gold standard' definition exists. The Leeds criteria are commonly used but may lack sensitivity for chronic P. aeruginosa. We compared clinicians' decision with the Leeds criteria in three adult CF centres. Two independent prospective datasets (Sheffield dataset, n = 185 adults; ACtiF pilot dataset, n = 62 adults from two different centres) were analysed. Clinicians involved in deciding P. aeruginosa status were blinded to the study objectives. Clinicians considered more adults with CF to have chronic P. aeruginosa infection compared to the Leeds criteria. This was more so for the Sheffield dataset (106/185, 57.3% with clinicians' decision vs. 80/185, 43.2% with the Leeds criteria; kappa coefficient between these two methods 0.72) compared to the ACtiF pilot dataset (34/62, 54.8% with clinicians' decision vs. 30/62, 48.4% with the Leeds criteria; kappa coefficient between these two methods 0.82). However, clinicians across different centres were relatively consistent once age and severity of lung disease, as indicated by the type of respiratory samples provided, were taken into account. Agreement in P. aeruginosa status was similar for both datasets among adults who predominantly provided sputum samples (kappa coefficient 0.78) or adults > 25 years old (kappa coefficient 0.82). Across three different centres, clinicians did not always agree with the Leeds criteria and tended to consider the Leeds criteria to lack sensitivity. Where disagreement occurred, clinicians tended to diagnose chronic P. aeruginosa infection because other relevant information was considered. These results suggest that a better definition for chronic P. aeruginosa might be developed by using consensus methods to move beyond a definition wholly dependent on standard microbiological results.

摘要

铜绿假单胞菌状态影响囊性纤维化(CF)的临床管理,但目前尚不存在“金标准”定义。利兹标准被广泛应用,但可能对慢性铜绿假单胞菌感染缺乏敏感性。我们在三个成人 CF 中心比较了临床医生的决策与利兹标准。分析了两个独立的前瞻性数据集(谢菲尔德数据集,n=185 名成人;ACtiF 试点数据集,n=来自两个不同中心的 62 名成人)。参与决定铜绿假单胞菌状态的临床医生对研究目标不知情。与利兹标准相比,临床医生认为更多的 CF 患者存在慢性铜绿假单胞菌感染。谢菲尔德数据集更为明显(106/185,临床医生决策为 57.3%,而利兹标准为 80/185,43.2%;这两种方法之间的kappa 系数为 0.72),而 ACtiF 试点数据集则不太明显(34/62,临床医生决策为 54.8%,而利兹标准为 30/62,48.4%;这两种方法之间的kappa 系数为 0.82)。然而,一旦考虑到年龄和肺部疾病的严重程度(由提供的呼吸道样本类型指示),不同中心的临床医生就相对一致。在主要提供痰样本的成年人(kappa 系数 0.78)或年龄大于 25 岁的成年人(kappa 系数 0.82)中,两个数据集的铜绿假单胞菌状态的一致性相似。在三个不同的中心,临床医生并不总是同意利兹标准,而且往往认为利兹标准缺乏敏感性。在出现分歧的情况下,临床医生往往会诊断为慢性铜绿假单胞菌感染,因为考虑到了其他相关信息。这些结果表明,可以通过使用共识方法来制定更好的慢性铜绿假单胞菌定义,从而超越完全依赖标准微生物学结果的定义。